Does BUPRENORPHINE Cause Malignant neoplasm progression? 17 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Malignant neoplasm progression have been filed in association with BUPRENORPHINE (Buprenorphine and Naloxone). This represents 0.0% of all adverse event reports for BUPRENORPHINE.
17
Reports of Malignant neoplasm progression with BUPRENORPHINE
0.0%
of all BUPRENORPHINE reports
11
Deaths
8
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BUPRENORPHINE?
Of the 17 reports, 11 (64.7%) resulted in death, 8 (47.1%) required hospitalization, and 2 (11.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does BUPRENORPHINE Cause?
Drug dependence (16,730)
Overdose (13,977)
Death (13,604)
Toxicity to various agents (10,906)
Pain (8,219)
Drug withdrawal syndrome (7,149)
Emotional distress (6,159)
Drug abuse (4,344)
Drug ineffective (4,261)
Dependence (3,184)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BUPRENORPHINE Alternatives Have Lower Malignant neoplasm progression Risk?
BUPRENORPHINE vs BUPRENORPHINE\NALOXONE
BUPRENORPHINE vs BUPROPION
BUPRENORPHINE vs BUPROPION HYDROBROMIDE
BUPRENORPHINE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE
BUPRENORPHINE vs BUPROPION\NALTREXONE